OCGNOcugen, Inc.

OCGN Stock Price, Valuation & Chart | Ocugen, Inc.

Compare

$1.320-0.01 (-0.75%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology OCGN intrinsic value OCGN calculated fair value vs price

Overview Financials Dividends Ratios

OCGN Historical price chart

OCGN Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization447.63M

PE Ratio-5.08

EPS-0.26

Trading Volume4.27M

Today's High/Low1.37/1.31

Dividend Yield0.00

52 Week High/Low2.73/1.01

Shares Outstanding339.11M

OCGN Financial Statement

OCGN Analyst ratings

OCGN Analysis & performance metrics

OCGN Company profile

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400,…

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410,…

OCGN Management team

Name

Position

John Kouch J.D.

General Counsel

Huma Qamar CMI, M.D., M.P.H.

Chief Medical Officer

Kristen Craft

Head of People & Culture

Michael Shine M.B.A.

Senior Vice President of Commercial

Arun Upadhyay Ph.D.

Chief Scientific Officer and Head of Research & Development

Tiffany J. Hamilton M.B.A.

AVice President & Head of Corporate Communications

Shankar Musunuri M.B.A., Ph.D.CEO

Co-Founder, Chief Executive Officer & Chairman

Ramesh Ramachandran C.M.A., CPA, M.B.A.

Chief Accounting Officer, Principal Financial Officer & Principal Accounting Officer

Name

Position

John Kouch J.D.

General Counsel

Huma Qamar CMI, M.D., M.P.H.

Chief Medical Officer

Kristen Craft

Head of People & Culture

Michael Shine M.B.A.

Senior Vice President of Commercial

Arun Upadhyay Ph.D.

Chief Scientific Officer and Head of Research & Development

Tiffany J. Hamilton M.B.A.

AVice President & Head of Corporate Communications

Shankar Musunuri M.B.A., Ph.D.CEO

Co-Founder, Chief Executive Officer & Chairman

Ramesh Ramachandran C.M.A., CPA, M.B.A.

Chief Accounting Officer, Principal Financial Officer & Principal Accounting Officer

Management Team

John Kouch J.D.

General Counsel

Huma Qamar CMI, M.D., M.P.H.

Chief Medical Officer

Kristen Craft

Head of People & Culture

Michael Shine M.B.A.

Senior Vice President of Commercial

Arun Upadhyay Ph.D.

Chief Scientific Officer and Head of Research & Development

Tiffany J. Hamilton M.B.A.

AVice President & Head of Corporate Communications

Shankar Musunuri M.B.A., Ph.D.CEO

Co-Founder, Chief Executive Officer & Chairman

Ramesh Ramachandran C.M.A., CPA, M.B.A.

Chief Accounting Officer, Principal Financial Officer & Principal Accounting Officer

Management

John Kouch J.D.

General Counsel

Huma Qamar CMI, M.D., M.P.H.

Chief Medical Officer

Kristen Craft

Head of People & Culture

Michael Shine M.B.A.

Senior Vice President of Commercial

Arun Upadhyay Ph.D.

Chief Scientific Officer and Head of Research & Development

Tiffany J. Hamilton M.B.A.

AVice President & Head of Corporate Communications

Shankar Musunuri M.B.A., Ph.D.CEO

Co-Founder, Chief Executive Officer & Chairman

Ramesh Ramachandran C.M.A., CPA, M.B.A.

Chief Accounting Officer, Principal Financial Officer & Principal Accounting Officer

Total 8 executives

OCGN Frequently asked questions

What is Ocugen, Inc. (OCGN) Stock Price?

Current stock price of Ocugen, Inc. (OCGN) stock is $1.320. The stock price is -0.75% lower in the session. The intraday range can be seen from this page. Volume of Ocugen, Inc. (OCGN) stock is 4.27M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Ocugen, Inc. (OCGN) stock price going up or down today?

The stock price of Ocugen, Inc. (OCGN) can change with earnings, company news, and overall market sentiment. Ocugen, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Ocugen, Inc. stock expensive at its current price?

Whether Ocugen, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for OCGN on this page is -5.08. EPS on this page is -0.26. Compare those figures with peers and growth expectations before deciding if the current Ocugen, Inc. price is justified.

How has the stock price of Ocugen, Inc. (OCGN) performed historically?

Historical performance for Ocugen, Inc. (OCGN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how OCGN reacted to past earnings and market events.

Should I buy Ocugen, Inc. (OCGN) stock, at this price?

Buying Ocugen, Inc. (OCGN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.